Mark J. Casey, J.D.

Mark J. Casey, J.D.

EVP, Chief Legal Officer and Corporate SecretaryatNovavax· In proxies 2023–2025

Pay in FY2025+165% from the year before · Novavax stock -16.4% the same year

Mark J. Casey, J.D. was paid $2.8M in FY2025 (Dec), up 165%. Novavax stock fell 16.4% that year.

Pay$100 in the stock at the end of FY22 → $65
Pay is from the Summary Compensation Table of each Novavax proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovavaxPublic company · 3 yr
    • EVP, Chief Legal Officer and Corporate Secretary2023 – Present · 3 yrStock in role +16%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?